Eli Lilly & Co. (LLY)
988.16
+20.23
(+2.09%)
USD |
NYSE |
May 05, 16:00
985.50
-2.66
(-0.27%)
After-Hours: 20:00
Eli Lilly Cash from Investing (Quarterly) : -3.916B for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | -428.90M |
| Viking Therapeutics, Inc. | 54.19M |
| Apellis Pharmaceuticals, Inc. | -0.108M |
| Arcellx, Inc. | 57.80M |
| Moderna, Inc. | -76.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.333B |
| Cash from Financing (Quarterly) | -3.47B |
| Free Cash Flow | 10.37B |
| Free Cash Flow Per Share (Quarterly) | 3.129 |
| Free Cash Flow to Equity (Quarterly) | 3.298B |
| Free Cash Flow to Firm (Quarterly) | 3.014B |
| Free Cash Flow Yield | 1.15% |